Acute Aortic Disease.. - Index of

140 Botta et al.
3. Johansson G, Markstrom U, Swedenborg J. Ruptured thoracic aortic aneurysms:
a study of incidence and mortality rates. J Vasc Surg 1995; 21(6):985–988.
4. Centers for Disease Control and Prevention: National Center for Health Statistics,
National Hospital Discharge Survey. United States Centers for Disease Control. 2001,
Table 42.
5. Miller CC III, Porat EE, Estrera AL, Vinnerkvist AN, Huynh TT, Safi HJ. Number
needed to treat: analyzing of the effectiveness of thoracoabdominal aortic repair.
Eur J Vasc Endovasc Surg 2004; 28(2):154–157.
6. Rizzo JA, Coady MA, Elefteriades JA. Procedures for estimating growth rates in
thoracic aortic aneurysms. J Clin Epidemiol 1998; 51(9):747–754.
7. Rizzo JA, Coady MA, Elefteriades JA. Interpreting data on thoracic aortic aneurysms.
Statistical issues. Cardiol Clin 1999; 17(4):797–805.
8. Coady MA, Rizzo JA, Elefteriades JA. Developing surgical intervention criteria for
thoracic aortic aneurysms. Cardiol Clin 1999; 17(4):827–839.
9. Elefteriades JA. Natural history of thoracic aortic aneurysms: indications for surgery,
and surgical versus nonsurgical risks. Ann Thorac Surg 2002; 74(5):S1877–1880.
Discussion S1892–1898.
10. Davies RR, Gallo A, Coady MA, et al. Novel measurement of relative aortic size
predicts rupture of thoracic aortic aneurysms. Ann Thorac Surg 2006; 81(1):169–177.
11. Koullias G, Modak R, Tranquilli M, Korkolis DP, Barash P, Elefteriades JA. Mechanical
deterioration underlies malignant behavior of aneurysmal human ascending aorta.
J Thorac Cardiovasc Surg 2005; 130(3):677–683.
12. Coady MA, Davies RR, Roberts M, et al. Familial patterns of thoracic aortic aneurysms.
Arch Surg 1999; 134(4):361–367.
13. Davies RR, Goldstein LJ, Coady MA, et al. Yearly rupture or dissection rates for
thoracic aortic aneurysms: simple prediction based on size. Ann Thorac Surg 2002;
73(1):17–27. Discussion 27–28.
14. Goldstein LJ, Davies RR, Rizzo JA, et al. Stroke in surgery of the thoracic aorta:
incidence, impact, etiology, and prevention. J Thorac Cardiovasc Surg 2001; 122(5):
935–945.
15. Ikonomidis JS, Gibson WC, Gardner J, et al. A murine model of thoracic aortic
aneurysms. J Surg Res 2003; 115(1):157–163.
16. Galis ZS, Sukhova GK, Kranzhofer R, Clark S, Libby P. Macrophage foam cells
from experimental atheroma constitutively produce matrix-degrading proteinases.
Proc Natl Acad Sci U S A 1995; 92(2):402–406.
17. Wassef M, Baxter BT, Chisholm RL, et al. Pathogenesis of abdominal aortic aneurysms:
a multidisciplinary research program supported by the National Heart, Lung,
and Blood Institute. J Vasc Surg 2001; 34(4):730–738.
18. Davies MJ. Aortic aneurysm formation: lessons from human studies and experimental
models. Circulation 1998; 98(3):193–195.
19. Lemaitre V, Soloway PD, D’Armiento J. Increased medial degradation with pseudoaneurysm
formation in apolipoprotein E-knockout mice deficient in tissue inhibitor
of metalloproteinases-1. Circulation 2003; 107(2):333–338.
20. Freestone T, Turner RJ, Coady A, Higman DJ, Greenhalgh RM, Powell JT. Inflammation
and matrix metalloproteinases in the enlarging abdominal aortic aneurysm. Arterioscler
Thromb Vasc Biol 1995; 15(8):1145–1451.
21. Sakalihasan N, Delvenne P, Nusgens BV, Limet R, Lapiere CM. Activated forms of
MMP2 and MMP9 in abdominal aortic aneurysms. J Vasc Surg 1996; 24(1):127–133.
22. Petersen E, Wagberg F, Angquist KA. Proteolysis of the abdominal aortic aneurysm
wall and the association with rupture. Eur J Vasc Endovasc Surg 2002; 23(2):153–157.